Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
F1000Research|March 26, 2025
Is relief the most common reaction to abortion? Self-assessed intensity of emotions attributed to abortion in a national sample of women aged 41 to 45David ReardonHandbook of Clinical Neurology|March 8, 2016
Rare glial tumorsRiccardo Soffietti, Roberta Rudà, David ReardonOpen Heart|June 9, 2022
Elevated cardiovascular disease risk in low-income women with a history of pregnancy lossMaka Tsulukidze, David Reardon, Christopher CraverCancer|September 9, 2010
Treatment recommendations for primary extradural meningiomasAustin Mattox, Betsy Hughes, James Oleson, et al.Clinical Transplantation|August 19, 2020
Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia prophylaxisWhitney Fu, Maria Barahona, Taylor Harkness, et al.Targeted Oncology|September 8, 2010
Targeting integrins in malignant gliomaGhazaleh Tabatabai, Michael Weller, Burt Nabors, et al.Neuroimage|December 24, 2008
Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MRA over four yearsElizabeth Bullitt, Matthew Ewend, James Vredenburgh, et al.Investigational New Drugs|November 13, 2014
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastomaDavid Schiff, Santosh Kesari, John de Groot, et al.Scientific Reports|January 28, 2021
Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastomaAndrew J Brenner, John Floyd, Lisa Fichtel, et al.Neuro-Oncology|November 13, 2007
Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutationSridharan Gururangan, Wendy Frankel, Russell Broaddus, et al.Pageof 3